We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+39.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.91B
AUM Growth
+$647M
Cap. Flow
-$57.9M
Cap. Flow %
-1.99%
Top 10 Hldgs %
34.16%
Holding
142
New
8
Increased
32
Reduced
31
Closed
11

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$68.4M
2
XYL icon
Xylem
XYL
+$29M
3
ROP icon
Roper Technologies
ROP
+$21.6M
4
VMC icon
Vulcan Materials
VMC
+$16.1M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$13.4M

Top Sells

Rank Stock Value
1
SEND
SendGrid, Inc.
SEND
+$77.4M
2
LOXO
Loxo Oncology, Inc
LOXO
+$38.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$36.4M
4
PANW icon
Palo Alto Networks
PANW
+$19.8M
5
SAGE
Sage Therapeutics
SAGE
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 46.61%
2 Technology 21%
3 Consumer Discretionary 9.25%
4 Industrials 6.6%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
26
Mettler-Toledo International
MTD
$27B
$34.7M 1.19%
48,000
+14,000
+41% +$9.1M
COLL icon
27
Collegium Pharmaceutical
COLL
$1.16B
$33.4M 1.15%
2,207,610
– –
ASML icon
28
ASML
ASML
$626B
$32.5M 1.12%
173,000
– –
QURE icon
29
uniQure
QURE
$2.64B
$32.1M 1.11%
538,700
-197,509
-27% -$8.82M
XYL icon
30
Xylem
XYL
$28.7B
$31.4M 1.08%
+397,000
New +$29M
OPLN
31
Openlane
OPLN
$4.26B
$31.3M 1.08%
1,611,620
– –
VMC icon
32
Vulcan Materials
VMC
$36.8B
$30.7M 1.06%
259,000
+149,000
+135% +$16.1M
MGA icon
33
Magna International
MGA
$17.9B
$29.9M 1.03%
613,700
– –
MNTA
34
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$29.5M 1.02%
2,033,144
+59,683
+3% +$762K
IMMU
35
DELISTED
Immunomedics Inc
IMMU
$27.1M 0.93%
1,412,000
– –
PAYC icon
36
Paycom
PAYC
$7.24B
$26.7M 0.92%
141,000
– –
STLD icon
37
Steel Dynamics
STLD
$35.6B
$26.6M 0.92%
754,000
– –
KALV
38
DELISTED
KalVista Pharmaceuticals
KALV
$25.8M 0.89%
900,000
– –
BHVN
39
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$25.4M 0.87%
493,000
– –
VRNS icon
40
Varonis Systems
VRNS
$5.33B
$25M 0.86%
1,260,000
-696,000
-36% -$13.2M
LEA icon
41
Lear
LEA
$7.19B
$25M 0.86%
184,000
– –
IPHI
42
DELISTED
INPHI CORPORATION
IPHI
$24.3M 0.84%
555,000
– –
INST
43
DELISTED
Instructure, Inc.
INST
$24.3M 0.84%
515,000
-290,796
-36% -$12.2M
NBIX icon
44
Neurocrine Biosciences
NBIX
$17.8B
$23.8M 0.82%
270,000
+114,000
+73% +$9.53M
VCYT icon
45
Veracyte
VCYT
$4.45B
$23.3M 0.8%
930,000
– –
ALTR
46
DELISTED
Altair Engineering Inc
ALTR
$23.1M 0.8%
628,000
-372,000
-37% -$12.5M
ICPT
47
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$22.9M 0.79%
205,000
+37,000
+22% +$4.04M
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$22.7M 0.78%
437,000
+135,000
+45% +$6.22M
PEGI
49
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$22.7M 0.78%
1,030,000
-15,000
-1% -$313K
CTAS icon
50
Cintas
CTAS
$84.6B
$22.4M 0.77%
444,000
+244,000
+122% +$11.8M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Eventide Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Eventide Asset Management held 142 positions worth $2.91B, up 29% from $2.26B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Eventide Asset Management's Q1 2019 filing shows 8 new, 32 increased, 31 reduced and 11 closed positions. Its largest new stake was Xylem: 397,000 shares worth $31.4M. The largest sale was SendGrid, Inc., an estimated $77.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q1 2019 buy was Xylem: 397,000 shares worth $31.4M.
  • Eventide Asset Management added most to Twilio in Q1 2019, an estimated $68.4M increase.
  • Eventide Asset Management's biggest Q1 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $36.4M.
  • Eventide Asset Management fully exited SendGrid, Inc. in Q1 2019, selling an estimated $77.4M.
  • Eventide Asset Management's ten largest holdings make up 34% of its $2.91B portfolio in Q1 2019.
  • Eventide Asset Management opened 8 new positions and closed 11 in Q1 2019.
  • Eventide Asset Management's portfolio value rose 29% quarter-over-quarter to $2.91B.

Based on Eventide Asset Management's 13F filing for Q1 2019, filed 15 May 2019.